Articles tagged "Kidney"

2022 American Transplant Congress
Feasibility and Short-Term Outcomes of Kidney Transplantation Following Donation After Circulatory Death Using Thoracic Normothermic Regional Perfusion in the United States
L. Hickman, D. Shaffer, J. Hoffman, W. G. McMaster, A. S. Shah, R. Forbes
Surgery, Vanderbilt University Medical Center, Nashville, TN
*Purpose: Organ donation after circulatory death (DCD) is an important component of kidney transplants in the US. Cardiac transplantation from DCD donors has previously been…
2022 American Transplant Congress
Impact of Cyp 3a5 Genotype on Lcp Tacrolimus Dosing and Monitoring in Kidney Transplantation
D. J. Taber, T. Carcella, N. Patel, F. Bartlett, A. Posadas, V. Rao, M. Casey, V. Rohan, D. Dubay, D. Taber
Med Univ of South Carolina, Charleston, SC
*Purpose: LCP Tacrolimus has a recommended de novo starting dose of 0.14 mg/kg/day in kidney transplantation (KTR). There is limited data on the influence of…
2022 American Transplant Congress
Racial Differences in the Predictability of Donor-Derived Cell-Free DNA Among Renal Transplant Recipients
M. D. Williams¹, N. Nimmagadda¹, S. Patel², O. Olaitan¹
¹Rush University Medical Center, Chicago, IL, ²CareDx, Brisbane, CA
*Purpose: Donor-Derived Cell-Free DNA (dd-cfDNA) is used to monitor for allograft rejection following renal transplantation. Baseline dd-cfDNA is higher in African American (AA) patients compared…
2022 American Transplant Congress
Evaluation of a Change in Pharmacy Discharge Medication Education for Kidney Transplant Recipients
M. Borsh¹, M. Leick¹, A. Donovan², C. McAdam-Marx², M. Keck¹
¹Pharmacy, Nebraska Medicine, Omaha, NE, ²College of Pharmacy, University of Nebraska Medical Center, Omaha, NE
*Purpose: To evaluate if modification of pharmacy discharge education for kidney transplant recipients contributed to a decreased length of hospital stay (LOS) post-transplant.*Methods: This was…
2021 American Transplant Congress
Precision Medicine Tools in Kidney Transplant (KTx): Implications for Individualized Immunosupression Therapy and Downstream Cost-savings
S. Anand, J. Sanchez-Garcia, L. Dong, M. Fife, J. Krong, D. Morris, T. Srinivas
Intermountain Medical Center, Murray, UT
*Purpose: Kidney Tissue Transcriptomics (Tr) is an emerging adjunct to traditional histology for diagnosis of kidney rejection in KTx. The objective assessment and reliance on…
2021 American Transplant Congress
Treatment of Biopsy-Proven Pyelonephritis of the Transplanted Kidney is Associated with Better Graft Outcomes
F. Aziz, C. Saddler, J. Alstott, K. Swanson, S. Parajuli, N. Garg, A. Djamali, D. Mandelbrot
University of Wisconsin, Madison, WI
*Purpose: The outcomes of treatment of pyelonephritis of the transplant kidney is not known.*Methods: From 01/1998 to 12/2019, 101 patients were found to have pyelonephritis…
2021 American Transplant Congress
Associations of Lack of Insurance and Other Sociodemographic Traits with Deficiencies in Follow-Up After Living Kidney Donation
K. Lentine¹, R. Hays², N. Lam³, A. Tietjen⁴, A. Muiru⁵, H. Xiao¹, A. Garg⁶, C. Thomas⁷, G. McNatt⁷, R. Howey⁸, U. Lebron-Banks⁹, M. Cooper¹⁰, M. Conboy¹¹, B. Kasiske¹¹
¹Saint Louis Univ, Saint Louis, MO, ²Univ of Wisconsin, Madison, WI, ³Univ of Calgary, Calgary, AB, Canada, ⁴St. Barnabas, Livingston, NJ, ⁵Univ of California, San Francisco, San Francisco, CA, ⁶Western Univ, London, ON, Canada, ⁷Univ of Iowa, Iowa City, IA, ⁸Toyon Associates, Concord, CA, ⁹New York Presb Hosp, New York, NY, ¹⁰Medstar-Georgetown, Washington, DC, ¹¹SRTR, Minneapolis, MN
*Purpose: Follow-up after living kidney donation in the United States has improved with recent policy mandates. We hypothesized that lack of insurance at donation may…
2021 American Transplant Congress
A Reliable Non Invasive Alternative to Surveillance Renal Allograft Biopsy
R. Jain, S. Thaduri, V. Kumar, C. Kew, B. Julian, G. Towns, S. Ong, F. Ahmed, S. Mehta, G. Agarwal
Transplant Nephrology, University of Alabama Birmingham, Birmingham, AL
*Purpose:Surveillance Renal Allograft Biopsy (SAVB) is the standard of care to identify subclinical immunological injury(SCI). However fewer than 25% of transplant centers in the US…
2021 American Transplant Congress
Exploring the Correlation with Donor Hepatitis C Viral Load and Viral Kinetics in Naïve Kidney Transplantation Recipients
A. Brooks¹, A. Rechnitzer¹, R. Teo¹, D. Y. Goldstein², M. Narlieva², J. P. Rocca¹, M. Ajaimy¹, L. Liriano-Ward¹, Y. Azzi¹, C. Pynadath¹, P. Loarte-Campos¹, E. Akalin¹, M. E. Le¹, H. Yaffe¹, S. Greenstein¹, J. Torabi¹, M. M. Kinkhabwala¹, J. A. Graham¹
¹Montefiore-Einstein Center for Transplantation, Montefiore Medical Center, Bronx, NY, ²Pathology, Montefiore Medical Center, Bronx, NY
*Purpose: The transplantation of Hepatitis C viremic (HCV) kidneys into uninfected recipients was made possible by effective direct acting anti-viral (DAA) therapy. This study aims…
2021 American Transplant Congress
Immunosuppression Regimen and Risk of Posttransplant Diabetes Among Older Kidney Transplant Recipients
K. Lentine¹, J. Ahn², M. McAdams Demarco², H. Xiao¹, S. Bunnapradist³, D. Segev², D. Axelrod¹, S. Bae², V. Dharnidharka⁴, Y. Caliskan¹, S. Chang⁴, G. Hess⁵, J. Snyder⁶, M. Schnitzler¹
¹Saint Louis Univ, Saint Louis, MO, ²Johns Hopkins, Baltimore, MD, ³Univ of California, Los Angeles, Los Angeles, CA, ⁴Washington Univ, Saint Louis, MO, ⁵Drexel Univ, Philadelphia, PA, ⁶SRTR, Minneapolis, MN
*Purpose: Posttransplant diabetes mellitus (PTDM) is a common complication after kidney transplantation (KTx), which may be exacerbated by immunosuppressive therapy (ISx). Older adults tend to…